- PDB-2q3l: CRYSTAL STRUCTURE OF AN UNCHARACTERIZED PROTEIN FROM DUF3478 FAMI... -
+
Open data
ID or keywords:
Loading...
-
Basic information
Entry
Database: PDB / ID: 2q3l
Title
CRYSTAL STRUCTURE OF AN UNCHARACTERIZED PROTEIN FROM DUF3478 FAMILY WITH A SPOIIAA-LIKE FOLD (SHEW_3102) FROM SHEWANELLA LOIHICA PV-4 AT 2.25 A RESOLUTION
Components
Uncharacterized protein
Keywords
UNKNOWN FUNCTION / SPOIIAA-LIKE FOLD / STRUCTURAL GENOMICS / JOINT CENTER FOR STRUCTURAL GENOMICS / JCSG / PROTEIN STRUCTURE INITIATIVE / PSI-2
BIOMOLECULE: 1 THIS ENTRY CONTAINS THE CRYSTALLOGRAPHIC ASYMMETRIC UNIT WHICH CONSISTS OF 2 ... BIOMOLECULE: 1 THIS ENTRY CONTAINS THE CRYSTALLOGRAPHIC ASYMMETRIC UNIT WHICH CONSISTS OF 2 CHAIN(S). SEE REMARK 350 FOR INFORMATION ON GENERATING THE BIOLOGICAL MOLECULE(S). SIZE EXCLUSION CHROMATOGRAPHY SUPPORTS THE ASSIGNMENT OF A DIMER AS A SIGNIFICANT OLIGOMERIZATION STATE IN SOLUTION.
Remark 600
HETEROGEN THE MPD USED AS A CRYOPROTECTANT WAS A RACEMIC MIXTURE: (4R,S)-2-METHYL-2,4-PENTANEDIOL
Remark 999
SEQUENCE THE CONSTRUCT WAS EXPRESSED WITH A PURIFICATION TAG MGSDKIHHHHHHENLYFQG. THE TAG WAS ... SEQUENCE THE CONSTRUCT WAS EXPRESSED WITH A PURIFICATION TAG MGSDKIHHHHHHENLYFQG. THE TAG WAS REMOVED WITH TEV PROTEASE LEAVING ONLY A GLYCINE (0) FOLLOWED BY THE TARGET SEQUENCE.
Type: MARMOSAIC 325 mm CCD / Detector: CCD / Date: May 14, 2007 / Details: Flat mirror (vertical focusing)
Radiation
Monochromator: Single crystal Si(111) bent (horizontal focusing) Protocol: MAD / Monochromatic (M) / Laue (L): M / Scattering type: x-ray
Radiation wavelength
ID
Wavelength (Å)
Relative weight
1
0.91837
1
2
0.97926
1
3
0.97895
1
Reflection
Resolution: 2.25→28.653 Å / Num. obs: 14575 / % possible obs: 99 % / Redundancy: 7.2 % / Biso Wilson estimate: 41.73 Å2 / Rmerge(I) obs: 0.067 / Rsym value: 0.067 / Net I/σ(I): 17.89
Reflection shell
Diffraction-ID: 1
Resolution (Å)
Redundancy (%)
Rmerge(I) obs
Mean I/σ(I) obs
Num. measured all
Num. unique all
Rsym value
% possible all
2.25-2.31
7
0.467
3.6
7445
1060
0.467
100
2.31-2.37
7.1
0.395
1.9
7192
1011
0.395
97.1
2.37-2.44
7.2
0.343
2.2
7188
998
0.343
99.7
2.44-2.52
7.2
0.276
2.8
7172
991
0.276
98.1
2.52-2.6
7.3
0.248
3.1
6827
931
0.248
99.4
2.6-2.69
7.3
0.184
4.1
6696
917
0.184
97.9
2.69-2.79
7.3
0.145
5.1
6460
880
0.145
99.8
2.79-2.9
7.3
0.132
5.6
6291
859
0.132
98
2.9-3.03
7.3
0.11
6.2
6062
829
0.11
100
3.03-3.18
7.3
0.086
8.1
5779
792
0.086
98.3
3.18-3.35
7.2
0.068
9.5
5531
769
0.068
99.1
3.35-3.56
7.3
0.058
11
5111
698
0.058
99.6
3.56-3.8
7.2
0.051
12.7
4870
675
0.051
98.7
3.8-4.11
7.1
0.045
13.6
4468
628
0.045
99.2
4.11-4.5
7.1
0.039
16.8
4195
589
0.039
99.4
4.5-5.03
7
0.036
16.7
3828
543
0.036
99.7
5.03-5.81
7
0.043
14.8
3304
472
0.043
99.2
5.81-7.12
6.9
0.049
13.1
2782
406
0.049
99.7
7.12-10.06
6.6
0.042
15.5
2224
339
0.042
99.7
10.06-28.653
6
0.033
19
1121
188
0.033
95.6
-
Phasing
Phasing
Method: MAD
-
Processing
Software
Name
Version
Classification
NB
REFMAC
5.2.0005
refinement
PHENIX
refinement
SHELX
phasing
MolProbity
3beta29
modelbuilding
SCALA
datascaling
PDB_EXTRACT
3
dataextraction
MAR345
CCD
datacollection
MOSFLM
datareduction
SHELXD
phasing
autoSHARP
phasing
Refinement
Method to determine structure: MAD / Resolution: 2.25→28.653 Å / Cor.coef. Fo:Fc: 0.959 / Cor.coef. Fo:Fc free: 0.93 / SU B: 12.875 / SU ML: 0.168 / TLS residual ADP flag: LIKELY RESIDUAL / Cross valid method: THROUGHOUT / σ(F): 0 / ESU R: 0.264 / ESU R Free: 0.216 Stereochemistry target values: MAXIMUM LIKELIHOOD WITH PHASES Details: 1. HYDROGENS HAVE BEEN ADDED IN THE RIDING POSITIONS. 2. ATOM RECORD CONTAINS RESIDUAL B FACTORS ONLY. 3. A MET-INHIBITION PROTOCOL WAS USED FOR SELENOMETHIONINE INCORPORATION DURING PROTEIN ...Details: 1. HYDROGENS HAVE BEEN ADDED IN THE RIDING POSITIONS. 2. ATOM RECORD CONTAINS RESIDUAL B FACTORS ONLY. 3. A MET-INHIBITION PROTOCOL WAS USED FOR SELENOMETHIONINE INCORPORATION DURING PROTEIN EXPRESSION. THE OCCUPANCY OF THE SE ATOMS IN THE MSE RESIDUES WAS REDUCED TO 0.75 TO ACCOUNT FOR THE REDUCED SCATTERING POWER DUE TO PARTIAL S-MET INCORPORATION. 4. SODIUM IONS, CHLORIDE IONS AND 2-METHYL-2,4-PENTANEDIOL (MPD) MOLECULES FROM CRYSTALIZATION ARE MODELED IN THE STRUCTURE. 5. ONE GLYCINE FROM PROTEIN EXPRESSION TAG AT N-TERMINAL IS ALSO BUILT IN EACH SUBUNIT. 6. RESIDUES 49 TO 52 IN SUBUNIT B ARE DISORDERED AND NOT BUILT IN THE MODEL.
Rfactor
Num. reflection
% reflection
Selection details
Rfree
0.239
754
5.2 %
RANDOM
Rwork
0.181
-
-
-
obs
0.184
14570
98.78 %
-
Solvent computation
Ion probe radii: 0.8 Å / Shrinkage radii: 0.8 Å / VDW probe radii: 1.2 Å / Solvent model: MASK
In the structure databanks used in Yorodumi, some data are registered as the other names, "COVID-19 virus" and "2019-nCoV". Here are the details of the virus and the list of structure data.
Jan 31, 2019. EMDB accession codes are about to change! (news from PDBe EMDB page)
EMDB accession codes are about to change! (news from PDBe EMDB page)
The allocation of 4 digits for EMDB accession codes will soon come to an end. Whilst these codes will remain in use, new EMDB accession codes will include an additional digit and will expand incrementally as the available range of codes is exhausted. The current 4-digit format prefixed with “EMD-” (i.e. EMD-XXXX) will advance to a 5-digit format (i.e. EMD-XXXXX), and so on. It is currently estimated that the 4-digit codes will be depleted around Spring 2019, at which point the 5-digit format will come into force.
The EM Navigator/Yorodumi systems omit the EMD- prefix.
Related info.:Q: What is EMD? / ID/Accession-code notation in Yorodumi/EM Navigator
Yorodumi is a browser for structure data from EMDB, PDB, SASBDB, etc.
This page is also the successor to EM Navigator detail page, and also detail information page/front-end page for Omokage search.
The word "yorodu" (or yorozu) is an old Japanese word meaning "ten thousand". "mi" (miru) is to see.
Related info.:EMDB / PDB / SASBDB / Comparison of 3 databanks / Yorodumi Search / Aug 31, 2016. New EM Navigator & Yorodumi / Yorodumi Papers / Jmol/JSmol / Function and homology information / Changes in new EM Navigator and Yorodumi